COVID Vaccine And Processed Goods Stocks Drop After Robert F. Kennedy Jr Nomination

Source: Reuters, Yahoo

Shares of vaccine makers and packaged food companies have recently taken a hit. This decline comes as Robert F. Kennedy Jr. nomination to becoming the U.S. Secretary of Health and Human Services. They know investigations into the truth are about begin.

Kennedy has been a controversial figure in the mainstream media due to his skepticism about the safety and efficacy of vaccines. Those are the same reasons he is celebrated by child healthcare advocates and Frontline Doctors fighting against the He has also criticized additives, chemicals, and sugar in packaged foods, which he believes contribute to chronic illnesses in the United States. As a result, stocks of companies like Pfizer, BioNTech, Moderna, Novavax, Hershey, Mondelez, Kraft Heinz, and General Mills have all seen declines.

To many families and providers under the Frontline Doctors network this is what accountability looks like. A clear message that our health and the health of our children are no longer for sale to the highest bidder at the FDA and the market has responded accordingly. For decades the legacy media and scientist turned a blind eye to chemicals which many other countries have already banned at the expense of our lives and finances.

Fortunately the Make America Healthy Again movement is hitting stride. The people who dared to question the FDA, CDC, and NIH and were ostracized and villainized for fighting for our health are now tasked with draining the swamp and restructuring the future of America’s health for decades to come.

For more questions on what processed foods you should avoid and whether alternatives to the vaccine are better for your health schedule an appointment with Frontline Doctors today.


Discover more from Frontline News Network

Subscribe to get the latest posts sent to your email.

Leave a Comment

Your email address will not be published. Required fields are marked *

Discover more from Frontline News Network

Subscribe now to keep reading and get access to the full archive.

Continue reading